JBS to open Brazil’s first cultivated protein research center

26 Sep 2023 --- JBS has commenced construction of Brazil’s first cultivated protein R&D innovation center. Scheduled to open at the end of next year, the JBS Biotech Innovation Centre at Sapiens Parque innovation hub in Florianópolis, Santa Catarina, will be Brazil’s biggest research facility focused on food biotechnology.

The JBS Biotech Innovation Centre will require approximately US$62 million in investment over three phases. In the third stage, an industrial-scale model will be built to demonstrate cultivated protein’s technical and economic viability. This project will serve as a model for future plants that JBS may build globally to produce beef and other cultivated protein types.

JBS’ cultivated protein will initially reach consumers in the form of prepared foods, such as hamburgers, sausages and meatballs, among others, with the same quality, safety, flavor and texture as traditional protein. 

The technology has the potential to produce beef, as well as chicken, pork and fish.

The company will invest US$22 million in the construction of lab facilities (phase 1) and the pilot plant (phase 2) and will have a scientific team of 25 specialist post-doctoral researchers and staff and clerical support. 

Expected to open at the end of 2024, the JBS Biotech Innovation Centre will be Brazil’s largest food biotechnology research center. (Image Credits: JBS).“As a global player in protein production, it is our responsibility to be at the forefront of food tech. The JBS Biotech Innovation Centre reinforces our commitment to the cultivated protein sector, consolidates our position as one of the main players in this promising market and reinforces our commitment to offering innovative, high-quality products to our consumers,” says JBS global supply and innovation director Jerson Nascimento Jr.

Cultivating protein 
The initial aim of the JBS Biotech Innovation Centre is to make the production process for cultivated protein more efficient, scalable and economically competitive. 

The project is being headed by Dr. Luismar Marques Porto, president of the company’s Cultivated Meat Division and the JBS Biotech Innovation Centre, and Fernanda Vieira Berti, vice-president of the Research Centre, two of Brazil’s leading bioengineering specialists.

“We are delighted to be part of the first initiative of this size in Brazil and to be able to contribute to studies that will help expand the sector. We are confident this project will become an international benchmark,” explains Porto.

The governor of Santa Catarina, Jorginho Mello, stressed that the JBS Biotech Innovation Centre reinforces the state’s innovation focus. 

“For those of us who grew up watching cattle graze from our windows in Herval D’Oeste, it’s almost out of this world to think of ‘cultivated protein.’ But as a public representative, it’s impossible not to see the future challenges, especially for countries that do not have as much land as Brazil to raise cattle. And it’s good to see Santa Catarina again championing breakthrough innovation,” he comments.

The mayor of Florianópolis, Topázio Neto, also highlighted the investment in innovation in the Santa Catarina capital. JBS’ cultivated protein will reach consumers in the form of prepared foods, such as hamburgers, sausages and meatballs.

“The investment of one of the world’s largest food companies in Florianópolis is very welcome. But we are especially proud that such an advanced global research project will be based in our city, which is a cradle of technology and innovation.”

Ongoing research & investments 
The scientists at the JBS Biotech Innovation Centre have already started work in temporary facilities within Sapiens Parque. While the current focus is on exploratory research to better understand beef cell cultivation, the aim is to establish cultivated beef protein production in the future.

In addition to the project in Florianópolis, JBS is the controlling shareholder (with a 51% stake) of Biotech Food. This Spanish company is one of the European leaders in the sector and currently operates a pilot plant in San Sebastián, in the Basque region.

At the end of last year, Biotech Foods began building a cultivated beef plant in San Sebastián, Spain. With an investment of US$41 million, BioTech Foods’ first commercial-scale industrial plant is scheduled for completion in mid-2024. 

The investment is a milestone in the sector, as when finished, the plant will be able to produce more than 1,000 metric tons of cultivated protein a year, possibly increasing its capacity to up to 4,000 metric tons per year.

Edited by Elizabeth Green 

To contact our editorial team please email us at editorial@cnsmedia.com